Endo International plc's long-term debt is $8B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest long-term debt for ENDP is $8B as of June 2022. That compares with $8.1B in the prior-year period — down 0.2% year over year. Investors often review this figure alongside Endo International plc's historical trend and sector peers before judging valuation or financial health.
Over the past year, ENDP's long-term debt moved from $8.1B to $8B — a 0.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Endo International plc's operating scale or balance-sheet position.
A long-term debt figure of $8B for ENDP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting ENDP's long-term debt ($8B), review year-over-year change from $8.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Endo International plc's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.